Discovery of a novel dual EGFR/HER-2 inhibitor

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 06期
关键词：
RESISTANCE; GEFITINIB;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：745 / 745
页数：1
相关论文
共 50 条
  • [31] EGFR and HER-2 co-targeting in cancer
    Modjtahedi, Helmout
    Khelwatty, Said Abdullah
    Essapen, Sharadah
    Seddon, Alan M.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S30 - S30
  • [32] HER-2 and EGFR: Possible Targets for Vulvar Carcinoma
    Rocha, R. M.
    Maia, B.
    Rocha, A.
    Rodrigues, I.
    Scares, F.
    LABORATORY INVESTIGATION, 2012, 92 : 295A - 295A
  • [33] Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
    Wang, C.
    Gao, H.
    Dong, J.
    Wang, F.
    Li, P.
    Zhang, J.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (11) : 1336 - 1350
  • [34] HER-2 and EGFR: Possible Targets for Vulvar Carcinoma
    Rocha, R. M.
    Maia, B.
    Rocha, A.
    Rodrigues, I.
    Soares, F.
    MODERN PATHOLOGY, 2012, 25 : 295A - 295A
  • [35] Dual targeting of RANKL/RANK pathway and HER-2 as a novel treatment strategy in HER-2 positive (1) breast carcinomas (BC)
    Zoi, I.
    Xingi, E.
    Thomaidou, D.
    Papavassiliou, A. G.
    Karamouzis, M. V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Sensitivity of EGFR/HER-2 Positive Cells Isolated from Ascitic Fluid of Advanced Ovarian Cancer Patients to EGFR/HER-2 Inhibitors
    Chitcholtan, Kenny
    Harker, Dianne
    Simcock, Bryony
    Sykes, Peter
    APPLIED SCIENCES-BASEL, 2020, 10 (07):
  • [37] Expression of the EGFR family of receptors (EGFR, HER-2, HER-3 and HER-4) in neuroendocrine tumours
    Srirajaskanthan, Rajaventhan
    Shah, Tahir
    Watkins, Jennifer
    Marelli, Laura
    Khan, Korsa
    Caplin, Martyn
    GASTROENTEROLOGY, 2008, 134 (04) : A299 - A299
  • [38] Navigating into the binding pockets of the HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent
    Liu, Wei
    Ning, Jin-Feng
    Meng, Qing-Wei
    Hu, Jing
    Zhao, Yan-Bin
    Liu, Chao
    Cai, Li
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3837 - 3851
  • [39] Lapatinib: A novel EGFR/HER2 tyrosine kinase inhibitor for cancer
    Johnston, Stephen R. D.
    Leary, Alex
    DRUGS OF TODAY, 2006, 42 (07) : 441 - 453
  • [40] Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
    Kim, Hwang-Phill
    Yoon, Young-Kwang
    Kim, Jin-Won
    Han, Sae-Won
    Hur, Hyung-Seok
    Park, Jinah
    Lee, Ju-Hee
    Oh, Do-Youn
    Im, Seock-Ah
    Bang, Yung-Jue
    Kim, Tae-You
    PLOS ONE, 2009, 4 (06):
12345